Worth Venture Partners, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 145 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$2,169,674
-1.1%
516,589
+41.5%
1.06%
-18.3%
Q4 2022$2,193,620–364,995–1.30%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders